SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-023203
Filing Date
2018-09-17
Accepted
2018-09-17 16:14:58
Documents
5
Period of Report
2018-09-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-8k_20180917.htm 8-K 33723
2 EX-10.1 rare-ex101_6.htm EX-10.1 66553
3 EX-99.1 rare-ex991_85.htm EX-99.1 11376
4 GRAPHIC gopu3ygjpsep000001.jpg GRAPHIC 348834
5 GRAPHIC gafp4m0yp42r000001.jpg GRAPHIC 348834
  Complete submission text file 0001564590-18-023203.txt   1073544
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 181073600
SIC: 2834 Pharmaceutical Preparations